U.S. Pharma Stock News

NasdaqGS:LMRI
NasdaqGS:LMRIHealthcare

Is It Time To Revisit Lumexa Imaging Holdings (LMRI) After Recent Healthcare Sector Focus?

If you are wondering whether Lumexa Imaging Holdings is attractively priced or not, you are in the right place. This article will walk you through what the current market price might be implying about its value. The share price recently closed at US$14.45, with a 30 day return of 33.8%, a 7 day return reflecting a 6.6% decline, and a year to date return showing a 17.7% decline. These changes can influence how investors think about both upside potential and risk. Recent news around Lumexa...
NasdaqGS:CASY
NasdaqGS:CASYConsumer Retailing

Casey’s General Stores Q3 Net Margin Expansion Tests High P E Bull Case

Casey’s General Stores (CASY) has put up another detailed scorecard for Q3 2026, with revenue of US$3.9 billion, basic EPS of US$3.51 and net income of US$130.1 million, while same store sales growth landed at 0.4%. The company has seen quarterly revenue move between US$3.9 billion and US$4.6 billion over the last few periods, with EPS ranging from US$2.35 to US$5.80 and trailing twelve month EPS at US$17.52 alongside net income of US$650.1 million. This sets the stage for investors to focus...
NYSE:VOYG
NYSE:VOYGAerospace & Defense

Voyager Technologies (VOYG) Posts US$116 Million Annual Loss Testing High-Growth Bullish Narratives

Voyager Technologies (VOYG) just closed FY 2025 with Q4 revenue of US$46.7 million and a basic EPS loss of US$0.52. Trailing 12 month revenue came in at US$166.4 million against a full year EPS loss of US$2.89 and revenue growth of 15.4% over the past year. The company has seen quarterly revenue range from US$34.5 million to US$46.7 million this year, with basic EPS losses stretching from US$0.28 to US$3.45 per quarter. Trailing 12 month net income excluding extra items was a loss of US$116.1...
NYSE:OI
NYSE:OIPackaging

A Look At O-I Glass (OI) Valuation After European Headwinds And Cost Savings Update

O-I Glass (OI) recently flagged tougher than expected trading in early 2026, citing softer European demand, temporary supply chain costs from factory closures, and pricing pressure in wine, while still keeping its full year guidance intact. See our latest analysis for O-I Glass. Those softer early 2026 trading conditions and European headwinds help explain why the 30 day share price return sits at a 29.89% decline and the year to date share price return is down 23.09%. At the same time, the 1...
NYSE:WLY
NYSE:WLYMedia

Assessing Wiley (WLY) Valuation After Q3 Profit Rebound AI Growth And Buybacks

John Wiley & Sons (WLY) is back in focus after reporting fiscal third quarter earnings that returned the business to profitability, alongside steady revenue, expanding AI driven research offerings, and active share repurchases. See our latest analysis for John Wiley & Sons. The recent Q3 profit rebound and ongoing buybacks appear to have shifted sentiment, with a 25.21% 1 month share price return and a 24.10% year to date share price return, even though the 1 year total shareholder return is...
NYSE:UHS
NYSE:UHSHealthcare

Is Universal Health Services (UHS) Attractive After Recent Pullback In Share Price

If you are wondering whether Universal Health Services is offering fair value at around US$186.53, you are not alone. This article focuses on what the numbers say about the stock today. The share price has pulled back recently, with an 8.9% decline over the last 7 days and a 14.7% decline over the last 30 days. However, the 1 year and 3 year returns of 8.5% and 62.2% respectively still stand out. Recent news around Universal Health Services has focused on the company as a key player in the...
NYSE:DG
NYSE:DGConsumer Retailing

Is Dollar General (DG) Still Attractively Priced After Mixed Share Price Performance?

If you are wondering whether Dollar General's share price around its recent US$146 close still offers value, you are not alone. This article is built to help you weigh what that price might actually represent. The stock has had a mixed run, with a 4.6% decline over the last 7 days, a 0.4% decline over 30 days, but a 6.7% gain year to date and an 89.7% return over the past year, set against 3-year and 5-year returns of 28.0% and 18.4% declines respectively. Recent coverage of Dollar General...
NasdaqGS:FSLY
NasdaqGS:FSLYIT

Fastly Auditor Switch To KPMG Raises Questions On Rally And Valuation

Fastly has appointed KPMG as its new independent registered public accounting firm, replacing Deloitte & Touche LLP. The change in auditor represents a shift in the company’s oversight of financial reporting and internal controls. For investors tracking NasdaqGS:FSLY, this auditor switch comes at a time when the stock price is $22.74 and recent returns have been very strong. The shares show a 7.6% return over the past week, 165.3% over the past month, 123.2% year to date, and 245.6% over...
NYSE:DGX
NYSE:DGXHealthcare

Quest Diagnostics Expands Preventive Reach With Shield Colorectal Blood Test

Quest Diagnostics (NYSE:DGX) has partnered with Guardant Health to offer the FDA approved Shield blood test for colorectal cancer screening. The agreement will make Shield available nationwide through Quest’s testing ecosystem, expanding access for patients and clinicians. The collaboration focuses on a blood based option for colorectal cancer screening that may support broader adoption of preventive care. For you as an investor, this move plugs directly into what Quest Diagnostics already...
NYSE:EPAM
NYSE:EPAMIT

Is It Time To Reassess EPAM Systems (EPAM) After Its Extended Share Price Slide?

If you are wondering whether EPAM Systems is starting to look like value after a tough run, this breakdown will help you frame the price you see against what you are actually getting. The stock last closed at US$142.18, with a 1% gain over the past week but declines of 23.8% over 30 days, 29.1% year to date and 25.7% over the past year, extending a 50.2% 3 year and 61.7% 5 year slide. Recent coverage around EPAM Systems has largely focused on its position within the software and IT services...
NYSE:APLE
NYSE:APLEHotel and Resort REITs

Is Apple Hospitality REIT (APLE) Offering Value After Recent Share Price Weakness

If you are wondering whether Apple Hospitality REIT is offering good value at its current price, this article will walk you through what the numbers are really saying about the stock. The shares recently closed at US$12.04, with returns of a 1.1% decline over 7 days, a 1.0% decline over 30 days, a 0.2% decline year to date, a 4.8% decline over 1 year, a 3.6% decline over 3 years and a 2.4% gain over 5 years. Recent attention on Apple Hospitality REIT has centered on its position in the US...
NasdaqGS:LKQ
NasdaqGS:LKQRetail Distributors

LKQ Board Change Raises Questions On Governance And Future Portfolio Moves

LKQ (NasdaqGS:LKQ) announced that board member Patrick Berard will step down after his current term and will not seek re election. The change affects the composition of LKQ's board of directors, an important body for governance and oversight. Investors may look at future board appointments for signals on company direction and oversight priorities. LKQ, a distributor of vehicle replacement and specialty parts, sits in the middle of trends around vehicle maintenance, repair, and aging car...
NYSE:SUN
NYSE:SUNOil and Gas

Sunoco Extends Debt Maturities As Refinancing Reshapes Interest Burden

Sunoco (NYSE:SUN) has priced a private offering of senior notes totaling US$1.2b. The offering has been upsized and is aimed at refinancing existing debt at Sunoco and NuStar Logistics. These transactions adjust the company’s capital structure and involve changes to key underwriters. Sunoco (NYSE:SUN) sits at the intersection of fuel distribution and energy infrastructure, where access to credit markets can be as important as operational performance. For investors tracking the sector,...
NasdaqGS:TIGO
NasdaqGS:TIGOWireless Telecom

Is It Too Late To Consider Millicom (NasdaqGS:TIGO) After Its 175% One-Year Surge?

If you are wondering whether Millicom International Cellular still offers good value after its strong run, or if you may be turning up late, this article focuses squarely on what you are paying versus what you may be getting. The stock last closed at US$72.84, with returns of 1.1% over 7 days, 8.8% over 30 days, 28.8% year to date, 175.4% over 1 year and 342.7% over 3 years. This naturally raises questions about how much optimism is already reflected in the price. Recent headlines around...
NYSE:USFD
NYSE:USFDConsumer Retailing

US Foods Reworks Deal Playbook After Shetakis Buy And Merger Exit

US Foods Holding (NYSE:USFD) signs a definitive agreement to acquire Shetakis, expanding its presence in the foodservice distribution space. The company ends its planned merger with Performance Foods after running into regulatory and economic hurdles. Together, these moves reshape US Foods Holding's growth playbook in a challenging foodservice market. US Foods Holding, one of the largest foodservice distributors in the US, operates in a sector facing cost pressures, changing restaurant...
NasdaqGS:VRTX
NasdaqGS:VRTXBiotechs

US Stock Market Today Stock Futures Edge Lower On Housing Jitters And Fed Uncertainty

The Morning Bull - US Market Morning Update Wednesday, Mar, 11 2026 US stock futures are slightly lower this morning, with E-mini S&P 500 contracts down about 0.1%, as investors weigh softer US housing confidence against steady bond markets and solid hiring. Existing home sales are running at an annual pace of 4.09 million, with prices near US$398,000, which matters for anyone thinking about moving or taking out a new mortgage. At the same time, the 10 year Treasury yield is holding around...
NasdaqGM:IRMD
NasdaqGM:IRMDMedical Equipment

Assessing IRADIMED (IRMD) Valuation After Strong Long Term Returns And A High P/E Multiple

IRADIMED (IRMD), a US based maker of MRI compatible medical devices, has drawn investor attention recently as its shares show mixed short term moves but a much stronger picture over the past year. See our latest analysis for IRADIMED. At a share price of US$98.95, IRADIMED has seen a 1 day share price return of 1.23% decline and a 7 day share price return of 5.13% decline, yet its 1 year total shareholder return of 91.95% and 5 year total shareholder return of 346.3% point to strong longer...
NYSE:WMS
NYSE:WMSBuilding

Is Advanced Drainage Systems (WMS) Quietly Recasting Its Balance Sheet To Support a New Growth Phase?

On February 27, 2026, Advanced Drainage Systems, Inc. fully redeemed its outstanding 5.000% Senior Notes due 2027 with an original principal of US$350 million, while also implementing a Fourth Amendment to its 2019 Credit Agreement that refinanced its term facility, extended loan maturities, and increased its revolving credit capacity. This combination of retiring fixed‑rate notes and expanding bank credit lines reshapes the company’s funding mix, potentially affecting interest costs,...
NasdaqGS:DLTR
NasdaqGS:DLTRConsumer Retailing

Is It Time To Reconsider Dollar Tree (DLTR) After Last Year’s 77.8% Surge?

If you are trying to figure out whether Dollar Tree is genuinely good value or just riding on sentiment, you are in the right place. The stock closed at US$116.82 recently, with returns of a 1.3% decline over 7 days, a 5.7% decline over 30 days, an 8.5% decline year to date and 77.8% over the last year, while the 3 year and 5 year returns sit at a 17.4% decline and 7.1% respectively. Those moves have come alongside ongoing attention on Dollar Tree's position in value retail. This includes...
NasdaqGS:KSPI
NasdaqGS:KSPIConsumer Finance

Kaspi.kz’s Higher Dividend and Softer Profit Raise Fresh Questions About Its Capital Allocation Strategy (KSPI)

Kaspi.kz recently proposed a quarterly dividend of KZT 850 per ADS and released its fourth-quarter and full-year 2025 results, showing higher revenue but lower quarterly net income than a year earlier. While full-year revenue climbed to about KZT 4.05 trillion with net income just above KZT 1.07 trillion, the mix of profit stability and a higher cash payout offers fresh context on how the company is balancing reinvestment and shareholder returns. We’ll now examine how the increased KZT 850...
NasdaqGS:EBAY
NasdaqGS:EBAYMultiline Retail

eBay Expands Resale And Live Shopping Push As Valuation Gap Persists

eBay expanded its integrated resale partnership with Klarna to six additional international markets, extending its embedded secondhand offering to more buyers and sellers. The company also launched a headline entertainment collaboration for eBay Live with the UK debut of NBC’s Saturday Night Live to promote interactive, shoppable content. For investors watching NasdaqGS:EBAY, these moves come as the stock trades at $90.86, with a 1 year return of 41.9% and a 3 year return that is very large...
NasdaqGS:HON
NasdaqGS:HONIndustrials

Is Honeywell International (HON) Pricing Reflect A DCF Premium And Automation Growth Story

If you are wondering whether Honeywell International's current share price lines up with its underlying worth, you are not alone, and that is exactly what this article is going to unpack. The stock recently closed at US$240.61, with a 1.3% decline over the last week, a 0.9% return over 30 days, and returns of 22.8% year to date, 25.1% over 1 year, 41.1% over 3 years, and 33.6% over 5 years. Recent news coverage has focused on Honeywell's positioning as a major industrial and technology...
NasdaqGS:ZVRA
NasdaqGS:ZVRAPharmaceuticals

Zevra Therapeutics (ZVRA) Profit Swing To US$77.6m TTM Tests Rare Disease Bull Case

Zevra Therapeutics (ZVRA) has wrapped up FY 2025 with Q4 total revenue of US$34.1 million and basic EPS of US$0.21, while trailing twelve month figures show total revenue of US$106.5 million and basic EPS of US$1.40. Over the past year, the company has seen total revenue move from US$23.6 million on a trailing basis in Q4 2024 to US$106.5 million by Q4 2025, alongside a shift from a trailing net loss of US$105.5 million to trailing net income of US$77.6 million. This sets the stage for a more...
NYSE:BWA
NYSE:BWAAuto Components

Did Analyst Upgrades Around BorgWarner’s EV Shift Just Reframe BWA’s Investment Narrative?

In recent days, BorgWarner has attracted renewed attention as UBS upgraded its rating to Neutral and other analysts adjusted their views amid the company’s transition toward electric-vehicle-focused parts. This wave of revised analyst opinions, including improved growth scores and higher consensus earnings estimates, highlights how expectations are evolving around BorgWarner’s shift in business mix and earnings profile. We’ll now examine how this fresh analyst optimism around BorgWarner’s...